Frontlight ResearchEarly access
Prostate cancer trials in United States
655 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in United StatesPRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy
- Where
- Boston
- Age
- 18 years and over
- People
- 20
- Run by
- Beth Israel Deaconess Medical Center
See details and how to joinNCT07516808 - No phaseTaking peopleMicroendoscopic EI Sensing for Real-time Intraoperative Surgical Margin Assessment
- Where
- Lebanon
- Age
- 18 years and over
- People
- 200
- Run by
- Ryan J. Halter
See details and how to joinNCT06039085 - Phase 1Taking peoplePhase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Where
- Austin, Fairfax, Plantation, San Antonio
- Age
- 18 years and over
- People
- 386
- Run by
- Conjupro Biotherapeutics, Inc.
See details and how to joinNCT07424547 - Phase 1/2Taking peopleA Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Where
- Atlanta, Boston, Cincinnati, Coral Gables, Detroit, Fairfax, Florham Park, Margate, Nashville, Orlando, Plantation, Sacramento, Santa Monica, Sarasota, Tamarac
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05785741 - No phaseTaking peopleAccuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Cancer
- Where
- Jacksonville
- Age
- 30 years to 85 years
- People
- 50
- Run by
- Mayo Clinic
See details and how to joinNCT06389786 - No phaseTaking peopleActive Surveillance SNEP Assay Registry Trial for Prostate Cancer
- Where
- Royal Oak
- Age
- 40 years to 80 years
- People
- 2,000
- Run by
- Immunis.AI
See details and how to joinNCT04052048 - Phase 1Taking peopleThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
- Where
- Austin, TX 78758, Boston, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Zumutor Biologics Inc.
See details and how to joinNCT06451497 - No phaseTaking peopleUsing a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
- Where
- Milledgeville, Oklahoma City, Tallahassee
- Age
- 18 years and over
- People
- 248
- Run by
- University of Oklahoma
See details and how to joinNCT06651359 - Phase 1Taking peopleAutologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC
- Where
- Tampa
- Age
- 18 years and over
- People
- 30
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06193486 - No phaseTaking peopleSBRT Boost for Unfavorable Prostate Cancer'
- Where
- Fountain Valley, Laguna Hills, Long Beach
- Age
- 18 years and over
- People
- 150
- Run by
- MemorialCare Health System
See details and how to joinNCT02016248 - Phase 3Taking peopleAdjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
- Where
- Dallas
- Age
- 30 years to 80 years
- People
- 650
- Run by
- yair lotan
See details and how to joinNCT02064673 - No phaseTaking peopleSPECT Imaging for Pharmacokinetics and dosimEtry Towards TREATment Optimization
- Where
- Baltimore
- Age
- 18 years to 100 years
- People
- 80
- Run by
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
See details and how to joinNCT06389097 - Phase 1/2Taking peopleA Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Where
- Boston, Chicago, Columbus, Fairfax, Houston, Jacksonville, New Haven, New York, Philadelphia, Phoenix, Rochester, Salt Lake City, Seattle
- Age
- 18 years and over
- People
- 120
- Run by
- 858 Therapeutics, Inc.
See details and how to joinNCT06395519 - No phaseTaking peoplePlasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 1,700 worldwide
- Run by
- Xijing Hospital
See details and how to joinNCT07492927 - Phase 2Taking peopleNeoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
- Where
- Hackensack, Washington D.C.
- Age
- 18 years and over
- People
- 54
- Run by
- Hackensack Meridian Health
See details and how to joinNCT06798558 - No phaseTaking peopleUtility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland Treatment
- Where
- Hackensack
- Age
- 18 years and over
- People
- 70
- Run by
- Hackensack Meridian Health
See details and how to joinNCT07011342 - Phase 1Taking peopleNovel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer
- Where
- Madison
- Age
- 18 years and over
- People
- 40
- Run by
- TechnoGenesys, Inc.
See details and how to joinNCT06705686 - No phaseTaking peopleMechanisms of Resistance to PSMA Radioligand Therapy
- Where
- Los Angeles, New York, San Francisco
- Age
- 18 years and over
- People
- 125
- Run by
- University of California, San Francisco
See details and how to joinNCT05435495 - No phaseTaking peopleAccess to Genetic Testing in Underserved Patients With Cancer
- Where
- Los Angeles, Rochester
- Age
- 18 years and over
- People
- 800
- Run by
- University of Southern California
See details and how to joinNCT06422455 - Phase 1/2Taking people64Cu-GRIP B in Patients With Advanced Malignancies
- Where
- San Francisco
- Age
- 18 years and over
- People
- 91
- Run by
- Rahul Aggarwal
See details and how to joinNCT05888532 - No phaseTaking peopleEngage Psychosocial Intervention for Cancer Symptoms
- Where
- Durham
- Age
- 18 years and over
- People
- 190
- Run by
- Duke University
See details and how to joinNCT06555588 - Phase 2Taking peopleAbiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer
- Where
- Sacramento
- Age
- 18 years and over
- People
- 75
- Run by
- University of California, Davis
See details and how to joinNCT06173362 - Phase 2Taking peopleRe-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial
- Where
- Los Angeles
- People
- 40
- Run by
- Jonsson Comprehensive Cancer Center
See details and how to joinNCT06288113 - Phase 1/2Taking peopleSafety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy
- Where
- St Louis
- Age
- 18 years and over
- People
- 36
- Run by
- Washington University School of Medicine
See details and how to joinNCT03424850 - Phase 2Taking peopleIntensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
- Where
- Los Angeles
- Age
- 18 years and over
- People
- 140
- Run by
- Cedars-Sinai Medical Center
See details and how to joinNCT06437574